印晓星, 张银娣. 美托洛尔光学异构体在犬体内的药动学-药效学结合模型J. 药学学报, 1997, 32(6): 411-415.
引用本文: 印晓星, 张银娣. 美托洛尔光学异构体在犬体内的药动学-药效学结合模型J. 药学学报, 1997, 32(6): 411-415.
XX Yin, YD Zhang. PHARMACOKINETIC PHARMACODYNAMIC MODELING OF METOPROLOL ENANTIOMERS IN THE DOGJ. Acta Pharmaceutica Sinica, 1997, 32(6): 411-415.
Citation: XX Yin, YD Zhang. PHARMACOKINETIC PHARMACODYNAMIC MODELING OF METOPROLOL ENANTIOMERS IN THE DOGJ. Acta Pharmaceutica Sinica, 1997, 32(6): 411-415.

美托洛尔光学异构体在犬体内的药动学-药效学结合模型

PHARMACOKINETIC PHARMACODYNAMIC MODELING OF METOPROLOL ENANTIOMERS IN THE DOG

  • 摘要: 用麻醉犬研究美托洛尔(Met)光学异构体药动学—药效学结合模型。结果表明,ig(+)-Met或(-)-Met后,其药动学符合二室模型,药动学参数Vd/F,CLs/F和AUC在两种Met之间有显著性差异。(+)-Met和(-)-Met的效应和血药浓度关系呈逆时针滞后环。引入效应室理论后,药效和效应室浓度之间的关系符合Sigmoid-Emax模型。应用CAPP软件进行模型拟合,血药浓度的预测值和药效的预测值皆与其实测值较为接近。(+)-Met抑制Vmax,dp/dtmax及HR效应的Ce50分别是(-)-Met的3.7,6.8,6.3倍,证实(-)-Met对犬心脏的抑制作用强于(+)-Met。

     

    Abstract: The PK-PD model of (+)-Met and (-)-Met was studied in anesthetized dogs. The plasma drug concentration-time profiles were most adequately described by two compartment model. Significant differences of Vd/F, CLs/F and AUC between (+)-Met and (-)-Met were observed. The peak times of plasma (+)-Met and (-)-Met concentration in dogs were 24±5 and 30±5 min, respectively. But the peak times of drug inhibitory effects on Vmax, dp/dtmax, LVSP, SBP and HR were about 90~120 min, showing the hysteresis loops. When using the effect compartment model, the counterclock-wise hysteresis collapsed and the relationships between the effects and concentration in effect compartment were fit by using Sigmoid-Emax model. The Ce50 velues of inhibitory effects on Vmax, dp/dtmax and HR of (+)-Met were 250±80, 450±210, 520±210 μg·L-1 and those of (-)-Met were 70±30, 70±40 and 82±27 μg·L-1, respectively. Significant differences of Ce50 of (+)-Met and (-)-Met were found. The values of Ce50+/Ce50- were 3.7, 6.8 and 6.3, indicating that the inhibitory effects on Vmax, dp/dtmax and HR of (-)-Met were stronger than those of (+)-Met in dogs.

     

/

返回文章
返回